About Drew

Every day is Chemo day for Drew. At 30 years of age, Drew was diagnosed with a rare and incurable form of Chronic Myeloid Leukemia (CML). Only 5,000 people a year in the United States are diagnosed with this disease, and because the cancer is caused by a chromosomal change, there is no way to cure it - only medication to keep it at bay. At the age of 38, it is extremely rare for someone like Drew to have this form of leukemia. It is normally diagnosed in people with an average age of 67, and the life expectancy is approximately 15 years. There are currently a lot of unknown facts surrounding Drew's case because physicians and oncologists do not often see CML in someone so young. And because of Drew's young age, his life expectancy is unknown.

What is known, is that Drew will have to take a maintenance chemo drug to manage the CML for the rest of his life, or until a cure is discovered. There are only a few drugs available at this time to treat this disease and because it is so rare, the demand for the drugs is low. Drew's medication can cost up to $6,000 and $8,000 a month. Medical Insurance only pays a portion of the entire cost of the drug. Additionally, there are other medical expenses not covered by insurance. Drew is faced with finding funding to make up the balance.

Due to COVID and Drew’s compromised immune system, his oncologist has advised him that he cannot return to his regular job. This has added to his financial strain.

This disease has been an incredible financial strain on Drew and with this medication, comes side effects that he must manage. Drew has met this challenge with his usual strength of determination, peace of soul, and warm and loving demeanor.

How can you help us make these dreams a reality?

Firstly, pray for Drew, his family, and a cure.

Secondly, you can donate by contacting us at drewscrewbenefit@gmail.com.

And lastly, support Drew by joining the 5k Run/Walk beginning at 11:00am on September 9, 2023 at Harman Park. Auction begins at 1:00pm.

Chronic Myelogenous Leukemia (CML) Is a cancer of the blood and bone marrow characterized by a genetic change in one's DNA in which pieces of chromosomes 9 and 22 fuse together. This fusion, called the Philadelphia Chromosome, creates a cancer gene that turns on the unregulated growth of white blood cells.

There's much more info at the American Cancer Society.

Read more


Want to help out or receive paper registration forms?

Email Us